Hypofractionated Intensity Modulated Radiation Therapy Altered Patterns of Failure in Patients With Glioblastoma Multiforme Treated on a Phase II Trial

被引：0
|
作者：
Reddy, K. [1 ]
Damek, D. [1 ]
Gaspar, L. E. [1 ]
Ney, D. [1 ]
Kavanagh, B. D. [1 ]
Waziri, A. [1 ]
Lillehei, K. [1 ]
Stuhr, K. [1 ]
Chen, C. [1 ]
机构：
[1] Univ Colorado Denver, Aurora, CO USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.699
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S268 / S268
页数：1
相关论文
共 50 条
  • [31] Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide
    Reddy, Krishna
    Gaspar, Laurie E.
    Kavanagh, Brian D.
    Waziri, Allen
    Damek, Denise M.
    Ney, Douglas
    Lillehei, Kevin O.
    Chen, Changhu
    JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (01) : 111 - 116
  • [32] HYPOFRACTIONATED RADIOTHERAPY WITH INTENSITY MODULATED ARC THERAPY (IMAT) PLUS ADJUVANT TEMOZOLOMIDE FOR PRIMARY GLIOBLASTOMA MULTIFORME
    D'Abbiero, N.
    Pisanello, A.
    De Berti, G.
    Iotti, C.
    Palmieri, T.
    Ramundo, D.
    Galeandro, M.
    Ruggieri, M.
    Riccardi, S.
    Lambertini, D.
    Bizzocchi, N.
    Ghadirpour, R.
    Armaroli, L.
    Marcello, N.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1073 - 1073
  • [33] Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide
    Krishna Reddy
    Laurie E. Gaspar
    Brian D. Kavanagh
    Allen Waziri
    Denise M. Damek
    Douglas Ney
    Kevin O. Lillehei
    Changhu Chen
    Journal of Neuro-Oncology, 2013, 114 : 111 - 116
  • [34] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    David M. Peereboom
    Dale R. Shepard
    Manmeet S. Ahluwalia
    Cathy J. Brewer
    Neeraj Agarwal
    Glen H. J. Stevens
    John H. Suh
    Steven A. Toms
    Michael A. Vogelbaum
    Robert J. Weil
    Paul Elson
    Gene H. Barnett
    Journal of Neuro-Oncology, 2010, 98 : 93 - 99
  • [35] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    Peereboom, David M.
    Shepard, Dale R.
    Ahluwalia, Manmeet S.
    Brewer, Cathy J.
    Agarwal, Neeraj
    Stevens, Glen H. J.
    Suh, John H.
    Toms, Steven A.
    Vogelbaum, Michael A.
    Weil, Robert J.
    Elson, Paul
    Barnett, Gene H.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 98 (01) : 93 - 99
  • [36] A phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM)
    Stieber, VW
    Tatter, SB
    Lovato, J
    Ellis, TL
    deGuzman, A
    Hinson, W
    Kearns, W
    Bourland, JD
    Rosdahl, R
    Lesser, G
    Stanton, C
    Shaw, E
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S261 - S261
  • [37] Phase I trial of erlotinib with radiation therapy (RT) in patients with glioblastoma multiforme (GBM)
    Krishnan, S
    Brown, P
    Ballman, K
    Fiveash, J
    Uhm, J
    Giannini, C
    Geoffroy, F
    Nabors, L
    Buckner, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 117S - 117S
  • [38] Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme
    Fuller, Clifton D.
    Choi, Mehee
    Forthuber, Britta
    Wang, Samuel J.
    Rajagiriyil, Nancy
    Salter, Bill J.
    Fuss, Martin
    RADIATION ONCOLOGY, 2007, 2 (1)
  • [39] Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme
    Clifton D Fuller
    Mehee Choi
    Britta Forthuber
    Samuel J Wang
    Nancy Rajagiriyil
    Bill J Salter
    Martin Fuss
    Radiation Oncology, 2
  • [40] Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia
    Maklad, Ahmed Marzouk
    Bayoumi, Yasser
    Hassan, Mohamed Abdalazez Senosy
    Elawadi, Abusaleh A.
    AlHussain, Hussain
    Elyamany, Ashraf
    Aldhahri, Saleh F.
    Al-Qahtani, Khalid Hussain
    AlQahtani, Mubarak
    Tunio, Mutahir A.
    ONCOTARGETS AND THERAPY, 2016, 9 : 6561 - 6567
12345